Treatment of patients with advanced neurofibromatosis type 2 (NF2) with novel molecularly targeted therapies.
V. Subbiah
No relevant relationships to disclose
J. M. Slopis
No relevant relationships to disclose
D. S. Hong
No relevant relationships to disclose
L. S. Angelo
No relevant relationships to disclose
I. E. McCutcheon
No relevant relationships to disclose
R. Kurzrock
No relevant relationships to disclose